China recalibrates drug pricing to balance costs and innovation
China is easing aggressive drug price cuts that threatened to undermine its pharmaceutical ambitions. The new pricing framework, unveiled last week, allows innovative drugs to command higher prices. The shift tests...To view the full article, register now.
Already a subscriber? Click here to view full article